Clinical Trial Update: Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating GSK3196165 plus methotrexate in active moderate-to-severe rheumatoid arthritis completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GSK3196165 (GSK3196165)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2019-04-04